I receive online articles from The Journal of Clinical Psychiatry. Yesterday, 6.10, they published highlights from a planning teleconference that discussed 'FM & Its Related Disorders' The research for this conference was funded by ELi Lilly, other drug companies and the NIH, the doctors doing research were paid by Eli Lilly, other drug companies and the NIH and since this article is published in a leading psychiatric journal and funded by the National Institute of Health, you may assume the article shares the public policy and opinion of the medical professions and the government about FM. In a nutshell: "The spectrum of fibromyalgia ranges from mild symptomology requiring no medical attention, to severe with disabling widespread pain and exhaustion. The progression from mild to severe symptoms is not well understood BUT DOES INVOLVE PERSONAL PSYCHOSOCIAL FACTORS. THEREFORE PRIMARY CARE PHYSICIANS SHOULD CONSIDER THE PSYCHOSOCIAL AS WELL AS THE PHYSIOLOGIC ASPECTS OF FIBROMYALGIA AND ITS RELATED DISORDERS (IBS, DEPRESSION, BI-POLAR, RHUEMATOID ARTHRITIS) TO PROVIDE PATIENTS WITH A COMPREHENSIVE TREATMENT PLAN THAT INCLUDES PHARMACOLOGIC AND NON-PHARMACOLOGIC TREATMENT OPTIONS." Based on their research these doctors agree that FM patients have emotional/psychiatric issues that manifest as physical disorders, and that it is essentially useless to treat only the medical problems or to view FM as a distinct medical disorder; the psychiatric issues must be acknowleged and treated at the same time, if not prior to the medical issues, for any resolution. For anyone hoping or waiting for the official position regarding FM to change from a psychiatric to a medical disorder, it seems this is not going to happen in the near future.